SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-000203
Filing Date
2023-01-03
Accepted
2023-01-03 16:24:20
Documents
2
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2909
2 POA DOCUMENT poa.txt EX-24 3549
  Complete submission text file 0001209191-23-000203.txt   7813
Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Issuer) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OBSEVA SA CHEMIN DES AULX, 12, 1228 PLAN-LES-OUATE GENEVA V8 1228
Business Address
Brown Stephanie Clare (Reporting) CIK: 0001959869 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37993 | Film No.: 23502420